Literature DB >> 12818410

New atherosclerosis risk factors in obese, hypertensive and diabetic children and adolescents.

Barbara Glowinska1, Miroslawa Urban, Alicja Koput, Marzena Galar.   

Abstract

UNLABELLED: In the last few years it has been proved that risk factors for atherosclerosis are present in children and adolescents, and that already at this early age they are connected with anatomic, atheromatous changes in vessels. These changes can not be fully explained as occurring in young people exhibiting traditional risk factors for the disease. The aim of the study was to evaluate levels of several new atherosclerosis risk factors (lipoprotein (a) (Lp(a)), apolipoprotein A-I (Apo A-I), apolipoprotein B (Apo B), homocysteine (Hcy), fibrinogen (FB), tissue plasminogen activator (t-PA) and tissue plasminogen activator inhibitor type 1 (PAI-1)) in children and adolescents with traditional risk factors (obesity, hypertension, diabetes).
MATERIALS AND METHODS: The study group consisted of 285 children and adolescents aged 14.3 years. Children were divided according to their main disease into groups: group A, children with obesity (n=49); group B, children with obesity and coexisting hypertension (n=56); group C, children with hypertension (n=58) and group D, children with diabetes (n=122). Control group consisted of 79 healthy children and adolescents aged 14.1 years. Lp(a), Apo A-I and Apo B levels were estimated by use of immunoturbidimetric methods; total Hcy, FB, t-PA and PAI-1 were estimated by use of immunoenzymatic methods.
RESULTS: Lp(a) level in the total study group was 30 mg/dl and was over twice higher than in control group, 14 mg/dl. Apo A-I level was significantly lower in group A (127.6 mg/dl) and in group B (125.8 mg/dl) versus 135.6 mg/dl in controls. The level of Apo B was significantly higher in total study group (86.2 mg/dl) and in groups A, B and D versus 73.5 mg/dl in controls. Hcy was higher in group B (8 micromol/l) and in group C (9.4 micromol/l) versus 6.2 micromol/l in the control group. The FB level was higher in the total study group (276.7 mg/dl) and in groups A (318.8 mg/dl) and B (322.6 mg/dl) versus 252.8 mg/dl in controls. Significantly higher t-PA level was found in groups A (9 ng/ml) and B (9.7 ng/ml) versus 7.3 ng/ml in controls, and PAI-1 level was significantly higher in the total study group (62.3 ng/ml) and in groups A (73.8 ng/ml), B (78 ng/ml) and C (73 ng/ml) versus 42.4 ng/ml in the control group. Correlation analysis showed significant relationship between body mass index (BMI) and Apo B, Hcy, FB, t-PA and PAI-1. Blood pressure values correlated positively with Hcy. Correlations were verified in multiple regression analysis models: FB and t-PA levels depended on BMI, and Hcy depended on systolic blood pressure.
CONCLUSIONS: (1) Young obese, hypertensive and diabetic patients present significant disturbances in lipid metabolism, regarding mainly total cholesterol, LDL, triglycerides, as well as Lp(a), Apo A-I and Apo B levels. Unfavourable lipid profile is characteristic mainly for children with obesity and accompanying hypertension. (2) Elevated Hcy levels are found in children with hypertension. (3) Elevated FB level and diminished fibrinolytic activity are characteristic of obese children.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12818410     DOI: 10.1016/s0021-9150(03)00003-0

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  26 in total

1.  Insulin resistance explains the relationship between novel cardiovascular risk factors and hypertension. The Telde Study.

Authors:  A M Wägner; J C Wiebe; M Boronat; P Saavedra; D Marrero; F Varillas; F J Nóvoa
Journal:  J Endocrinol Invest       Date:  2010-10-27       Impact factor: 4.256

2.  Elevated plasma homocysteine in obese schoolchildren with early atherosclerosis.

Authors:  Weihua Zhu; Xianmei Huang; Mengxia Li; Henning Neubauer
Journal:  Eur J Pediatr       Date:  2005-12-13       Impact factor: 3.183

Review 3.  A diagnostic approach for the child with hypertension.

Authors:  Natasa Marcun Varda; Alojz Gregoric
Journal:  Pediatr Nephrol       Date:  2005-02-19       Impact factor: 3.714

4.  Association of plasminogen activator inhibitor-1 and tissue plasminogen activator with type 2 diabetes and metabolic syndrome in Malaysian subjects.

Authors:  Zaid Al-Hamodi; Ikram S Ismail; Riyadh Saif-Ali; Khaled A Ahmed; Sekaran Muniandy
Journal:  Cardiovasc Diabetol       Date:  2011-03-18       Impact factor: 9.951

5.  Childhood obesity: a review of increased risk for physical and psychological comorbidities.

Authors:  Elizabeth R Pulgarón
Journal:  Clin Ther       Date:  2013-01       Impact factor: 3.393

6.  Cardiovascular risk factors in overweight and obese Chinese children: a comparison of weight-for-height index and BMI as the screening criterion.

Authors:  Cai-Xia Zhang; Lap-Ah Tse; Xue-Qing Deng; Zhuo-Qin Jiang
Journal:  Eur J Nutr       Date:  2008-06-28       Impact factor: 5.614

7.  Renal functional reserve in patients with Type 1 diabetes mellitus.

Authors:  Jelka Zaletel; Darko Cerne; Katarina Lenart; Sabine Zitta; Günther Jürgens; Willibald Estelberger; Andreja Kocijancic
Journal:  Wien Klin Wochenschr       Date:  2004-04-30       Impact factor: 1.704

Review 8.  Psyllium fibre and the metabolic control of obese children and adolescents.

Authors:  L A Moreno; B Tresaco; G Bueno; J Fleta; G Rodríguez; J M Garagorri; M Bueno
Journal:  J Physiol Biochem       Date:  2003-09       Impact factor: 4.158

9.  Serum homocysteine in Indian adolescents.

Authors:  Pratima Anand; Shally Awasthi; Abbas Mahdi; Manoj Tiwari; G G Agarwal
Journal:  Indian J Pediatr       Date:  2009-04-16       Impact factor: 1.967

10.  A list of candidate cancer biomarkers for targeted proteomics.

Authors:  Malu Polanski; N Leigh Anderson
Journal:  Biomark Insights       Date:  2007-02-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.